Clinical reference Biomarker Directory
Back to directory

Adenylate kinase enzyme

Emerging

Adenylate kinase deficiency is a very rare cause of hereditary hemolytic anemia from impaired red blood cell energy metabolism.

Also known as AK1 adenylate kinase 1
In plain language

This enzyme helps red blood cells manage their energy supply. A rare inherited shortage of it causes chronic anemia, similar to some of the other red-cell enzyme deficiencies discussed earlier, though this particular one is much rarer and less studied.

Biomarker & context

Adenylate kinase (AK1) is an enzyme involved in cellular energy metabolism, maintaining the balance of adenine nucleotides (ATP, ADP, AMP) within red blood cells.

What it indicates

Deficiency (AK1 deficiency) is a very rare cause of hereditary hemolytic anemia from impaired red blood cell energy metabolism, similar in concept to the pyruvate kinase deficiency discussed earlier, though far less common and less well-characterized clinically.

Diagnosis & clinical testing

Diagnosed via red blood cell enzyme activity assay when other, more common causes of hereditary hemolytic anemia (pyruvate kinase deficiency, G6PD deficiency, hereditary spherocytosis) have been excluded; genetic testing of the AK1 gene can confirm diagnosis.

Guiding treatment

Management is primarily supportive (transfusions as needed, folic acid supplementation, splenectomy in select cases), similar to management approaches for other red cell enzyme deficiencies, since no enzyme-specific therapy exists for this particular rare deficiency.

Clinical significance

Far less common and less well-characterized than other red cell enzyme deficiencies like pyruvate kinase deficiency.

References
  1. General hematology reference literature on rare red blood cell enzymopathies causing hereditary hemolytic anemia.